[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.207.116. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
July 18, 2001

The Pharmaceutical Industry and Continuing Education

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;286(3):302-304. doi:10.1001/jama.286.3.302

To the Editor: Dr Relman1 felt that it is inappropriate for industry to support continuing medical education (CME) while Mr Holmer2 felt that such support is constructive. I wonder if Relman and others who have written against such support have considered the inherent intelligence of the physicians and their rigorous scientific and clinical training that allow them to make appropriate judgments of industry-supported CME. To think otherwise would denigrate most physicians. I wonder if there are studies to show that physicians change their attitudes based on industry-supported CME that is not validated by appropriate research.

First Page Preview View Large
First page PDF preview
First page PDF preview
×